Xtant Medical Holdings, Inc. (XTNT): M&A transaction — Xtant completes secondary sale of 73.1M shares (52.5% stake) from OrbiMed to Nantahala; Q1 rev guidance $32.8-33.1M

Xtant Medical Holdings, Inc.

OrbiMed affiliates sold 73.1M shares (52.5% of outstanding) to Nantahala-led group at $0.42/share; OrbiMed now holds no Xtant shares.
Nantahala now owns 49.1% of Xtant (68.4M shares), becoming the largest stockholder and gaining effective control.
Investor rights agreement with OrbiMed terminated; company gains strategic and operational flexibility.
Preliminary Q1 2025 revenue expected $32.8M-$33.1M, up 18-19% YoY driven by orthobiologics and licensing.
Company loses NYSE American controlled company status; now must comply with independent director and committee rules.

item 1.02 item 2.02 item 5.01 item 7.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

Xtant Medical Holdings, Inc. underwent a change of control involving Nantahala Capital Management, LLC for approximately $30.7 million (closed 2025-04-15).

Action: change of control
Counterparty: Nantahala Capital Management, LLC
Consideration: approximately $30.7 million
Closing: 2025-04-15

Exact text from the filing

Pursuant to the Transaction, as described in the Introductory Note hereto, which is incorporated by reference into this Item 5.01, the Purchasers completed the acquisition of the Shares from the Sellers, constituting 52.5% of the Common Stock outstanding as of April 15, 2025 for approximately $30.7 million, which the Company believes was funded out of the Purchasers’ personal funds. The consummation of the Transaction resulted in a change in control of the Company, as a result of which the Sellers own no shares of Common Stock and Nantahala gained effective control of the Company by virtue of holding approximately 49.1% of the Company’s issued and outstanding Common Stock and being the largest stockholder of the Company.

View on SEC.gov

Browse all m&a transactions →

Xtant Medical Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001641172-25-005078

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.